Cost analysis of type 2 diabetes mellitus treatment in economically developed countries

References

• Diabetes.co.uk. Type 2 diabetes. [cited 2018 Mar 2]. Available from https://www.diabetes.co.uk/type2-diabetes.html
   Google Scholar
• Hsia Y, Neubert AC, Rani F, et al. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol. 2009;67(2):242–249.
   PubMed Web of Science ®Google Scholar
• IDF. International diabetes federation diabetes atlas. 8th. 2018. International Diabetes Federation. Available from: http://www.diabetesatlas.org/.
   Google Scholar
• Saito I, Kokubo Y, Yamagishi K, et al. Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis. 2011;216(1):187–191.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dall TM, Mann SE, et al. The economic costs of undiagnosed diabetes. Popul Health Manag. 2009;12(2):95–101.
   PubMed Web of Science ®Google Scholar
• Babar ZU, Grover P, Stewart J, et al. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm. 2011;7(3):294–305.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj, 339. 2009. DOI:10.1136/bmj.b2700
   Web of Science ®Google Scholar
• Barua A (2017). Global inflation: not yet a worry for most policymakers. [cited 2018 Mar 1]. Available from https://www2.deloitte.com/insights/us/en/economy/global-economic-outlook/2017/q2-global-inflation-not-yet-a-worry-for-central-banks.html
   Google Scholar
• Yahoo. (2018). Yahoo finance. [cited 2018 Mar 1]. Available from https://uk.finance.yahoo.com/currency-converter/
   Google Scholar
• Wong WC, Cheung CS, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol. 2008;5:23.
   PubMedGoogle Scholar
• Roman NF, Frantz JM. The prevalence of intimate partner violence in the family: a systematic review of the implications for adolescents in Africa. Fam Pract. 2013;30(3):228–246.
   Web of Science ®Google Scholar
• Louw QA, Morris LD, Grimmer-Somers K. The prevalence of low back pain in Africa: a systematic review. BMC Musculoskelet Disord. 2007;8:105.
   PubMed Web of Science ®Google Scholar
• Bahia LR, Araujo DV, Schaan BD, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian Public Health System. Value in Health. 2011;14(5 SUPPL):S137–S140.
   PubMed Web of Science ®Google Scholar
• Borges NB, Ferraz MB, Chacra AR. The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil. Diabetology Metab Syndr. 2014;6:1.
   PubMed Web of Science ®Google Scholar
• Demurtas J, Alba N, Rigon G, et al. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona. Prim Care Diabetes. 2017;11(6):570–576.
   PubMed Web of Science ®Google Scholar
• Domeikiene A, Vaivadaite J, Ivanauskiene R, et al. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina (Kaunas). 2014;50(1):54–60.
   PubMed Web of Science ®Google Scholar
• Elgart JF, Asteazaran S, De La Fuente JL, et al. Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina. Int J Public Health. 2014;59(5):851–857.
   PubMed Web of Science ®Google Scholar
• Jacob L, Von Vultee C, Kostev K. Prescription patterns and the cost of antihyperglycemic drugs in patients with type 2 diabetes mellitus in Germany. J Diabetes Sci Technol. 2017;11(1):123–127.
   PubMedGoogle Scholar
• Mata-Cases M, Casajuana M, Franch-Nadal J, et al. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain. Eur J Health Econ. 2016;17(8):1001–1010.
   PubMed Web of Science ®Google Scholar
• Ng CS, Toh MP, Ko Y, et al. Direct medical cost of type 2 diabetes in Singapore. PLoS ONE. 2015;10(3):e0122795.
   PubMed Web of Science ®Google Scholar
• Ulrich S, Holle R, Wacker M, et al. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies. BMJ Open. 2016;6(11):e012527.
   PubMed Web of Science ®Google Scholar
• Tharkar S, Devarajan A, Kumpatla S, et al. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract. 2010;89(3):334–340.
   PubMed Web of Science ®Google Scholar
• Wang W, McGreevey WP, Fu C, et al. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care. 2009;15(9):593–601.
   PubMed Web of Science ®Google Scholar
• Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia. 2002;45(7):S13–17.
   Web of Science ®Google Scholar
• Al-Maskari F, El-Sadig M, Nagelkerke N. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates. BMC Public Health. 2010;10:679.
   PubMed Web of Science ®Google Scholar
• Lee KW. Costs of diabetes mellitus in Korea. Diabetes Metab J. 2011;35(6):567–570.
   PubMedGoogle Scholar
• Jonsson B. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45(7):S5–12.
   PubMed Web of Science ®Google Scholar
• González CJ, Walker JH, Einarson TR. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Revista Panamericana De Salud Publica/Pan American Journal of Public Health. 2009;26(1):55–63.
   PubMed Web of Science ®Google Scholar
• Javanbakht M, Baradaran HR, Mashayekhi A, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS ONE. 2011;6:10.
   Web of Science ®Google Scholar
• Bolin K, Gip C, Mörk AC, et al. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005—a register-based approach. Diabetic Med. 2009;26(9):928–934.
   PubMed Web of Science ®Google Scholar
• ADA. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4): 1033–1046.
   PubMed Web of Science ®Google Scholar
• ADA. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31(3): 596–615.
   PubMed Web of Science ®Google Scholar
• Melander A, Folino-Gallo P, Walley T, et al. Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia. 2006;49(9):2024–2029.
   PubMed Web of Science ®Google Scholar
• King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–648. .
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559.
   PubMed Web of Science ®Google Scholar
• Tao B, Pietropaolo M, Atkinson M, et al. Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS ONE. 2010;5(7):e11501.
   PubMed Web of Science ®Google Scholar
• Bruno G, Karaghiosoff L, Merletti F, et al. The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia. 2008;51(5):795–801.
   PubMed Web of Science ®Google Scholar
• ADA. American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–928.
   PubMed Web of Science ®Google Scholar
• Koster I, Huppertz E, Hauner H, et al. Costs of Diabetes Mellitus (CoDiM) in Germany, direct per-capita costs of managing hyperglycaemia and diabetes complications in 2010 compared to 2001. Exp Clin Endocrinol Diabetes. 2014;122(9):510–516.
   PubMed Web of Science ®Google Scholar
• Koster I, Von Ferber L, Ihle P, et al. The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM study. Diabetologia. 2006;49(7):1498–1504.
   PubMed Web of Science ®Google Scholar